These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5528345)

  • 1. Studies on further attenuated live measles vaccine. II. Correlation between the titer of the vaccine, the antibody response and clinical reactions.
    Ueda S; Takahashi M; Minekawa Y; Ogino T; Suzuki N
    Biken J; 1970 Jun; 13(2):117-20. PubMed ID: 5528345
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on further attenuated live measles vaccine. I. Adaptation of measles virus to the chorioallantoic membrane of chick embryo and clinical tests on the strain.
    Ueda S; Takahashi M; Minekawa Y; Ogino T; Suzuki N
    Biken J; 1970 Jun; 13(2):111-6. PubMed ID: 5528344
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and immunologic observations on two lines of attenuated measles vaccine virus upon passage in chick embryo cell culture.
    Chun H; T'eh-chang H; Kuo-hua T; Shou-teh C; Wen-huan W; Chi-ming C; Yu-fen K; Chü-yeh Y; Lan H
    Chin Med J (Engl); 1975 Jul; 1(4):283-6. PubMed ID: 810334
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine.
    Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
    Kitasato Arch Exp Med; 1974 Jun; 47(1-2):13-21. PubMed ID: 4476032
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing attenuation of measles virus strain Sugiyama during serial passage in calf kidney cells.
    Kawana R; Kaneko M; Wako H; Iwai T; Kawana M
    Jpn J Exp Med; 1970 Aug; 40(4):257-63. PubMed ID: 5312395
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Materials on measles pathogenesis and vaccinal process.
    Sergiev PG; Shroit IG; Chelysheva KM; Smirnova EV; Kuksova MI; Shevtsova ZV; Levenshtam MA; Chernomordik AE; Kozlyuk AS; Stromova GI; Manjko TG; Yefimov EE; Shamrayeva SA; Voskresenskaya GS
    Acta Virol; 1966 Sep; 10(5):430-9. PubMed ID: 4380362
    [No Abstract]   [Full Text] [Related]  

  • 11. Measles virus for distemper prophylaxis.
    Gale C
    J Am Vet Med Assoc; 1970 Jun; 156(12):1751-2. PubMed ID: 5422525
    [No Abstract]   [Full Text] [Related]  

  • 12. Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety.
    de Swart RL; Kuiken T; Fernandez-de Castro J; Papania MJ; Bennett JV; Valdespino JL; Minor P; Witham CL; Yüksel S; Vos H; van Amerongen G; Osterhaus AD
    Vaccine; 2006 Sep; 24(40-41):6424-36. PubMed ID: 16934375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the modification of the live AIK measles vaccine. I. Adaptation of the further attenuated AIK measles virus (the strain AIK-L33) to chick embryo cells.
    Sasaki K
    Kitasato Arch Exp Med; 1974 Jun; 47(1-2):1-12. PubMed ID: 4217404
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidemiological analysis of cases with rash and fever illness after measles vaccine inoculation during 1999 to 2002 in Shandong province, China].
    Xu AQ; Xu Q; Song LZ; Xiao ZK; Zhang L; Wang CY; Wang TZ; Li RP; Li MS; Li Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):417-20. PubMed ID: 15231169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiences with the live measles virus vaccines L-4 and L-16 in the German Democratic Republic].
    Starke G
    Pathol Microbiol (Basel); 1965; 28(6):950-5. PubMed ID: 5879805
    [No Abstract]   [Full Text] [Related]  

  • 16. [Exanthema with high fever and cerebral seizure susceptibility after mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S; Bruns R; Mentel R
    Kinderarztl Prax; 1993 Aug; 61(6):227-8. PubMed ID: 8105135
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of live mumps vaccine alone and in combination with measles vaccine in infants].
    Vesikari T; Ala-Laurila EL; Heikkinen A; Kuusinen H; Terho A
    Duodecim; 1982; 98(11):839-47. PubMed ID: 7106018
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental studies on attenuated measles virus.
    Zahorska R; Mazur N
    Acta Microbiol Pol A; 1973; 5(3):251-8. PubMed ID: 4203634
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of host-incorporated antigens in the immune response to measles virus.
    Isacson P
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:139-45. PubMed ID: 4313661
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.
    Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D
    Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.